EP08.01-109 TACTI-002: A Phase II Study of Eftilagimod Alpha (Soluble LAG-3) & Pembrolizumab in 2nd line PD-1/PD-L1 Refractory Metastatic NSCLC

M. Forster, Matthew Krebs, Margarita Majem, J. Peguero, Tonya Clay, E. Felip, Wade Iams, Patricia Roxburgh, B. Doger, P. Bajaj, J. Kefas, J.-.A. Scott, Andrés Barba Joaquín, C. Mueller, F. Triebel

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S395
JournalJournal of Thoracic Oncology
Publication statusPublished - 1 Sept 2022

Cite this